Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555721 · ClinicalTrials.gov registry record
CytID Analysis of Oral Lesions
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- 18
- Enrollment target
NCT03555721 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 18 participants.
The verdict
NCT03555721 was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to correlate the results from a standard of care biopsy with CytID™ and hpvID™ swab tests for potentially premalignant and malignant oral lesions. The biopsy is considered standard of care and will be performed regardless of the patient's enrollment in the study. The study-related data gathering will not influence the treatment decisions of the clinician.
Interventions
- OTHER Oral examination with incandescent light
- OTHER Oral examination with OralID
- DIAGNOSTIC_TEST Biopsy
- DIAGNOSTIC_TEST CytID
- DIAGNOSTIC_TEST hpvID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-05-30 |
| Est. Completion | 2022-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03555721
The ClinicalTrials.gov registry entry for NCT03555721 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Oral examination with incandescent light is the first listed.
NCT03555721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03555721 about?
NCT03555721 is a clinical study titled "CytID Analysis of Oral Lesions". The purpose of this study is to correlate the results from a standard of care biopsy with CytID™ and hpvID™ swab tests for potentially premalignant and malignant oral lesions. The biopsy is considered standard of care and will be performed regardless of the patient's enrollment in the study. The stu...
What is the current status of trial NCT03555721?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2018-05-30. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03555721?
The interventions under investigation include: Oral examination with incandescent light (OTHER), Oral examination with OralID (OTHER), Biopsy (DIAGNOSTIC_TEST), CytID (DIAGNOSTIC_TEST), hpvID (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03555721?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.